As such, among all the genetic polymorphisms discussed, the influence of LYPLAL1 rs12137855 on the development of NAFLD remains the most contentious and subject to debate. This evidence concerns the gene LYPLAL1 and metabolic dysfunction-associated steatotic liver disease.